Inicio › Obesidad › Connecticut
Ensayos clínicos de Obesidad en Connecticut
22 estudios sobre Obesidad buscan participantes en Connecticut.
Ciudades en Connecticut
Texto oficial del estudio (inglés)
Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles
- University of Connecticut, Storrs
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 50 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07844616A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Yale School of Medicine - Yale Diabetes Center (YDC)) Trials, New Haven
- Stamford Therapeutics Consortium, Stamford
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- New England Research Associates, LLC, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- New England Research Associates, LLC, Bridgeport
- Yale University School of Medicine, New Haven
- Chase Medical Research, LLC, Waterbury
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Chase Medical Research, LLC, Waterbury
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07321886A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07589608Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Cardiology Associates of Fairfield County PC, Stamford
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Yale University, New Haven
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Waterbury
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 sept 2026 · NCT06143956Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Stamford
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Chase Medical Research LLC, Waterbury
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07684235Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Bridgeport
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07284875Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Hamden
- Kailera Clinical Site, Stamford
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07284979AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Chase Medical Research LLC, Waterbury
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT07509307A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
- UConn Health, Farmington
- Hartford HealthCare, Hartford
- University of Connecticut, Storrs
Reclutando
Edades de 18 a 64 · Todos los sexos · Actualizado el 12 ago 2026 · NCT07238556Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
- Hartford HealthCare, Hartford
Reclutando
Edades de 18 a 64 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06484621Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- Yale Pediatric Diabetes Center, Adult and Children's Progam, New Haven
ReclutandoFase 2
Edades de 18 a 30 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06411210A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Chase Medical Research LLC, Hamden
- Chase Medical Research LLC, Waterbury
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 jul 2026 · NCT07481630Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
- Yale University, New Haven
ReclutandoSe aceptan voluntarios sanos
Edades de 40 en adelante · Todos los sexos · Actualizado el 17 jun 2026 · NCT07376655New Mechanisms of Obesity
- Yale University, New Haven
Reclutando
Edades de 15 a 22 · Todos los sexos · Actualizado el 28 ene 2026 · NCT06768827Craving Network Neurofeedback
- Yale MRRC Anlyan Center, New Haven
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 60 · Todos los sexos · Actualizado el 3 dic 2025 · NCT06426693De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.